The DOI matches its Crossref record; 89 of the 90 references it cites were found in a registry or an index.
Baseline MRI Predictors of Conversion from MCI to Probable AD in the ADNI Cohort
Open accessAbstract
The Alzheimer's Disease Neuroimaging Initiative (ADNI) is a multi-center study assessing neuroimaging in diagnosis and longitudinal monitoring. Amnestic Mild Cognitive Impairment (MCI) often represents a prodromal form of dementia, conferring a 10-15% annual risk of converting to probable AD. We analyzed baseline 1.5T MRI scans in 693 participants from the ADNI cohort divided into four groups by baseline diagnosis and one year MCI to probable AD conversion status to identify neuroimaging phenotypes associated with MCI and AD and potential predictive markers of imminent conversion. MP-RAGE scans were analyzed using publicly available voxel-based morphometry (VBM) and automated parcellation methods. Measures included global and hippocampal grey matter (GM) density, hippocampal and amygdalar volumes, and cortical thickness values from entorhinal cortex and other temporal and parietal lobe regions. The overall pattern of structural MRI changes in MCI (n=339) and AD (n=148) compared to healthy controls (HC, n=206) was similar to prior findings in smaller samples. MCI-Converters (n=62) demonstrated a very similar pattern of atrophic changes to the AD group up to a year before meeting clinical criteria for AD. Finally, a comparison of effect sizes for contrasts between the MCI-Converters and MCI-Stable (n=277) groups on MRI metrics indicated that degree of neurodegeneration of medial temporal structures was the best antecedent MRI marker of imminent conversion, with decreased hippocampal volume (left > right) being the most robust. Validation of imaging biomarkers is important as they can help enrich clinical trials of disease modifying agents by identifying individuals at highest risk for progression to AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures



![Fig. (4). Extracted GM density, volume, and cortical thickness values from medial temporal lobe structures. Comparisons of GM density values (A) were extracted from the unmodulated VBM GM maps using standard left and right hippocampal ROIs traced on an independent sample of 40 HC participants [25, 58]. Bilateral hippocampal (B) and amygdalar (C) volume estimates and entorhinal cortex thickness values (D) were extracted using automated parcellation. The comparisons of all four MRI metrics show a significant difference (p<0.001) across all groups. In pairwise comparisons, hippocampal GM density, hippocampal and amygdala volumes, and entorhinal cortex thickness show significant differences between HC and all clinical groups (p<0.001) bilaterally and MCI-Stable and AD groups (p<0.001) bilaterally. Furthermore, MCI-Stable and MCI-Converter groups show significant differences in GM density and volume in the left (GM (A), p=0.001; volume (B), p<0.001) and right (GM (A), p=0.034; volume (B), p<0.001) hippocampi, as well as significant differences in amygdala volume on both the left (p<0.001) and right (p=0.01). MCI-Converters also showed significantly thinner entorhinal cortices than MCI-Stable participants on both the left (p=0.006) and right (p<0.001). No significant differences were found in hippocampal GM density, hippocampal or amygdalar volumes, or entorhinal cortex thickness values between MCI-Converter and AD groups. Age, gender, years of education, handedness, and ICV were included as covariates in all comparisons.](/paper-figures/7b93948ff2074bee96839e69a1dee4b1/baseline-mri-predictors-of-conversion-from-mci-to-probable-ad-in-the-adni-cohort-figure-4.jpg)



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“they reliably predict cognitive decline [222]”
From Genetic architecture of Alzheimer's disease (2020) · cites this paper as [222]
In the citing paper
“a large number of novel loci and genes have been nominated by these analyses [222, 229–231]”
From Genetic architecture of Alzheimer's disease (2020) · cites this paper as [222]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Cortical Surface-Based Analysis
Dale, A. M., Fischl, B., & Sereno, M. I. (1999) · NeuroImage · doi:10.1006/nimg.1998.0395 · Cited by 10,910
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
Mild Cognitive Impairment: Clinical Characterization and Outcome
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.303 · Cited by 8,980
Voxel-Based Morphometry—The Methods
Ashburner, J., & Friston, K. J. (2000) · NeuroImage · doi:10.1006/nimg.2000.0582 · Cited by 8,676
Fischl, B., Salat, D. H., Busa, E., Albert, M., Dieterich, M., Haselgrove, C., van der Kouwe, A., Killiany, R., Kennedy, D., Klaveness, S., et al. (2002) · Neuron · doi:10.1016/s0896-6273(02)00569-x · Cited by 8,610
Mild cognitive impairment as a diagnostic entity
Petersen, R. C. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01388.x · Cited by 7,864
Sheikh (1986) · doi:10.1300/j018v05n01_09 · Cited by 7,236
Cortical Surface-Based Analysis
Fischl, B., Sereno, M. I., & Dale, A. M. (1999) · NeuroImage · doi:10.1006/nimg.1998.0396 · Cited by 6,147
Measuring the thickness of the human cerebral cortex from magnetic resonance images
Fischl, B. R., & Dale, A. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.200033797 · Cited by 5,995
Research works printed but not linked: 1
- [35]Dickerson BC Goncharova I Sullivan MP Forchetti C Wilson RS Bennett DA MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer's disease Neurobiol Aging 2001 22 747 754 11705634
Cited by
Sorted by citations
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
Dubois, B., Feldman, H. H., Jacova, C., Hampel, H., Molinuevo, J. L., Blennow, K., DeKosky, S. T., Gauthier, S., Selkoe, D., Bateman, R., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70090-0 · Cited by 3,321
The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception
Weiner, M. W., Veitch, D. P., Aisen, P. S. S., Beckett, L. A., Cairns, N. J., Green, R. C., Harvey, D. J., Jack, C. R., Jagust, W. J., Liu, E., et al. (2013) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.05.1769 · Cited by 1,033
Self-citationSmith, A. D., Smith, S. M., de Jager, C. A., Whitbread, P., Johnston, C., Agacinski, G., Oulhaj, A., Bradley, K. M., Jacoby, R., & Refsum, H. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012244 · Cited by 813
“An intermediate rate of atrophy is found in people with mild cognitive impairment (MCI) [6,7,8,9,10,11].”
A phase I trial of deep brain stimulation of memory circuits in Alzheimer's disease
Laxton, A. W., Tang‐Wai, D. F., McAndrews, M. P., Zumsteg, D., Wennberg, R. A., Keren, R., Wherrett, J. R., Naglie, G., Hamani, C., Smith, G. S., et al. (2010) · Annals of Neurology · doi:10.1002/ana.22089 · Cited by 827
Multimodal Neuroimaging Feature Learning for Multiclass Diagnosis of Alzheimer's Disease
Liu, S., Liu, S., Cai, W., Che, H., Pujol, S., Kikinis, R., Feng, D., Fulham, M. J., & ADNI (2015) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2014.2372011 · Cited by 637
The Alzheimer's Disease Neuroimaging Initiative: Progress report and future plans
Weiner, M. W., Aisen, P. S. S., Jack, C. R., Jagust, W. J., Trojanowski, J. Q., Shaw, L. M. J., Saykin, A. J., Morris, J. C., Cairns, N. J., Beckett, L. A., et al. (2010) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.03.007 · Cited by 613
Self-citationPrediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification
Davatzikos, C. A., Bhatt, P., Shaw, L. M. J., Batmanghelich, K. N., & Trojanowski, J. Q. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.05.023 · Cited by 596
BrainAGE in Mild Cognitive Impaired Patients: Predicting the Conversion to Alzheimer’s Disease
Gaser, C., Franke, K., Klöppel, S., Koutsouleris, N., Sauer, H., & Initiative, A. D. N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067346 · Cited by 555
Jack, C. R., Wiste, H. J., Vemuri, P., Weigand, S. D., Senjem, M. L., Zeng, G., Bernstein, M. A., Gunter, J. L., Pankratz, V. S., Aisen, P. S., et al. (2010) · Brain · doi:10.1093/brain/awq277 · Cited by 531
The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception
Weiner, M. W., Veitch, D. P., Aisen, P. S. S., Beckett, L. A., Cairns, N. J., Green, R. C., Harvey, D. J., Jack, C. R., Jagust, W. J., Liu, E., et al. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.09.172 · Cited by 497
Self-citationSaykin, A. J., Shen, L., Foroud, T. M., Potkin, S. G., Swaminathan, S., Kim, S., Risacher, S. L., Nho, K., Huentelman, M. J., Craig, D. W., et al. (2010) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2010.03.013 · Cited by 442
Self-citationDocosahexaenoic Acid and Cognition throughout the Lifespan
Weiser, M., Butt, C., & Mohajeri, M. (2016) · Nutrients · doi:10.3390/nu8020099 · Cited by 400
Shen, L., Kim, S., Risacher, S. L., Nho, K. T., Swaminathan, S., West, J. D., Foroud, T., Pankratz, N., Moore, J. H., Sloan, C., et al. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.01.042 · Cited by 383
Self-citationWeiner, M. W., Veitch, D. P., Aisen, P. S., Beckett, L. A., Cairns, N. J., Cedarbaum, J., Green, R. C., Harvey, D., Jack, C. R., Jagust, W., et al. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.11.001 · Cited by 348
Self-citationEffectiveness of regional DTI measures in distinguishing Alzheimer’s disease, MCI, and normal aging
Nir, T. M., Jahanshad, N., Villalon-Reina, J. E., Toga, A. W., Jack, C. R., Weiner, M. W., & Thompson, P. M. (2013) · NeuroImage: Clinical · doi:10.1016/j.nicl.2013.07.006 · Cited by 348
Nho, K., Kueider‐Paisley, A., MahmoudianDehkordi, S., Arnold, M., Risacher, S. L., Louie, G., Blach, C., Baillie, R., Han, X., Kastenmüller, G., et al. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.08.012 · Cited by 343
Self-citationGomar, J. J. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.96 · Cited by 353
Song, T., Song, X., Zhu, C., Patrick, R., Skurla, M., Santangelo, I., Green, M., Harper, D., Ren, B., Forester, B. P., et al. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101503 · Cited by 346
McDonald, B. C., Conroy, S. K., Ahles, T. A., West, J. D., & Saykin, A. J. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1088-4 · Cited by 333
Self-citationType 2 diabetes mellitus and biomarkers of neurodegeneration
Moran, C., Beare, R. J., Phan, T. G., Bruce, D. G., Callisaya, M. L., & Srikanth, V. K. (2015) · Neurology · doi:10.1212/wnl.0000000000001982 · Cited by 298
Plancher, G., Tirard, A., Gyselinck, V., Nicolas, S., & Piolino, P. (2012) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2011.12.013 · Cited by 280
Longitudinal MRI atrophy biomarkers: Relationship to conversion in the ADNI cohort
Risacher, S. L., Shen, L., West, J. D., Kim, S., McDonald, B. C., Beckett, L. A., Harvey, D. J., Jack, C. R., Weiner, M. W., & Saykin, A. J. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.04.029 · Cited by 276
Self-citationChong-yaw Wee, A., Yap, P., Shen, D. G., & Initiative, A. D. N. (2012) · Human Brain Mapping · doi:10.1002/hbm.22156 · Cited by 261
Wang, H., Shen, Y., Wang, S., Xiao, T., Deng, L., Wang, X., & Zhao, X. (2018) · Neurocomputing · doi:10.1016/j.neucom.2018.12.018 · Cited by 261
Structural MRI changes detectable up to ten years before clinical Alzheimer's disease
Tondelli, M., Wilcock, G. K., Nichelli, P., de Jager, C. A., Jenkinson, M., & Zamboni, G. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.05.018 · Cited by 265
Neurostructural predictors of Alzheimer's disease: A meta-analysis of VBM studies
Ferreira, L. K., Diniz, B. S., Forlenza, O. V., Busatto, G. F., & Zanetti, M. V. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.11.008 · Cited by 241
Villain, N., Fouquet, M., Baron, J.-C., Mezenge, F., Landeau, B., de La Sayette, V., Viader, F., Eustache, F., Desgranges, B., & Chetelat, G. (2010) · Brain · doi:10.1093/brain/awq203 · Cited by 237
Cui, Y. J., Liu, B., Luo, S., Zhen, X., Fan, M., Liu, T., Zhu, W., Park, M., Jiang, T., Jin, J. S., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021896 · Cited by 238
Sex and age differences in atrophic rates: an ADNI study with n=1368 MRI scans
Hua, X., Hibar, D. P., Lee, S., Toga, A. W., Jack, C. R., Weiner, M. W., & Thompson, P. M. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.04.033 · Cited by 234
Biomarkers for the Early Detection and Progression of Alzheimer's Disease
Counts, S. E., Ikonomovic, M. D., Mercado, N., Vega, I. E., & Mufson, E. J. (2017) · Neurotherapeutics · doi:10.1007/s13311-016-0481-z · Cited by 224
Machine learning for comprehensive forecasting of Alzheimer’s Disease progression
Fisher, C. K., Smith, A. M., Walsh, J. R., Diseases, C. A. M., Simon, A. J., Edgar, C., Jack, C. R., Holtzman, D., Russell, D., Hill, D., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-49656-2 · Cited by 223
Jack, C. R., Barkhof, F., Bernstein, M. A., Cantillon, M., Cole, P. E., DeCarli, C. S., Dubois, B., Duchesne, S., Fox, N. C., Frisoni, G. B., et al. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.04.007 · Cited by 225
Automated hippocampal shape analysis predicts the onset of dementia in mild cognitive impairment
Costafreda, S. G., Dinov, I. D., Tu, Z., Shi, Y., Liu, C.-Y., Kłoszewska, I., Mecocci, P., Soininen, H. S., Tsolaki, M., Vellas, B. J., et al. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.01.050 · Cited by 220
Gollub, R. L., Shoemaker, J. M., King, M. D., White, T. J. H., Ehrlich, S., Sponheim, S. R., Clark, V. P., Turner, J. A., Mueller, B. A., Magnotta, V. A., et al. (2013) · Neuroinformatics · doi:10.1007/s12021-013-9184-3 · Cited by 212
Relevance of Magnetic Resonance Imaging for Early Detection and Diagnosis of Alzheimer Disease
Teipel, S. J., Grothe, M. J., Lista, S., Toschi, N., Garaci, F., & Hampel, H. J. (2013) · Medical Clinics of North America · doi:10.1016/j.mcna.2012.12.013 · Cited by 198
Jernerén, F., Elshorbagy, A. K., Oulhaj, A., Smith, S. M., Refsum, H., & Smith, A. D. (2015) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.103283 · Cited by 196
Abrol, A., Bhattarai, M., Fedorov, A., Du, Y., Plis, S., Calhoun, V. D., & Initiative, F. T. A. D. N. (2018) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2020.108701 · Cited by 194
Domain Transfer Learning for MCI Conversion Prediction
Cheng, B., Liu, M., Zhang, D., Munsell, B. C., & Shen, D. G. (2015) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2015.2404809 · Cited by 192
Wang, Y., Risacher, S. L., West, J. D., McDonald, B. C., Magee, T., Farlow, M. R., Gao, S., O’Neill, D. P., & Saykin, A. J. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130080 · Cited by 183
Self-citationGrothe, M. J., Heinsen, H., & Teipel, S. J. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.10.018 · Cited by 179
Iglesias, J. E., Leemput, K. V., Augustinack, J. C., Insausti, R., Fischl, B. R., & Reuter, M. (2016) · NeuroImage · doi:10.1016/j.neuroimage.2016.07.020 · Cited by 170
Omega-3 fatty acids and mental health
Lange, K. W. (2020) · Global Health Journal · doi:10.1016/j.glohj.2020.01.004 · Cited by 191
Ezzati, A., Katz, M. J., Zammit, A. R., Lipton, M. L., Zimmerman, M. E., Sliwinski, M. J., & Lipton, R. B. (2016) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2016.08.016 · Cited by 172
Computational Modeling of Dementia Prediction Using Deep Neural Network: Analysis on OASIS Dataset
Basheer, S., Bhatia, S., & Sakri, S. B. (2021) · IEEE Access · doi:10.1109/access.2021.3066213 · Cited by 185
Characterizing Alzheimer's disease using a hypometabolic convergence index
Chen, K., Ayutyanont, N., Langbaum, J. B. S., Fleisher, A., Reschke, C., Lee, W., Liu, X., Bandy, D., Alexander, G. E., Thompson, P. M., et al. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.01.049 · Cited by 165
Yang, J., Pan, P., Song, W., Huang, R., Li, J., Chen, K., Gong, Q., Zhong, J., Shi, H., & Shang, H. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.02.010 · Cited by 157
Subcortical volumes across the lifespan: Data from 18,605 healthy individuals aged 3–90 years
Dima, D., Modabbernia, A., Papachristou, E., Doucet, G. E., Agartz, I., Aghajani, M., Akudjedu, T. N., Albajes‐Eizagirre, A., Alnæs, D., Alpert, K. I., et al. (2021) · Human Brain Mapping · doi:10.1002/hbm.25320 · Cited by 165
Type 2 diabetes mellitus, brain atrophy, and cognitive decline
Moran, C., Beare, R. J., Wang, W., Callisaya, M. L., Srikanth, V. K., Initiative, A. D. N., Initiative, A. D. N., Weiner, M. W., Aisen, P., Weiner, M. W., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000006955 · Cited by 165
Self-citationBhagwat, N., Viviano, J. D., Voineskos, A. N., Chakravarty, M. M., & Initiative, A. D. N. (2018) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1006376 · Cited by 157
Furney, S. J., Simmons, A., Breen, G., Pedroso, I., Lunnon, K., Proitsi, P., Hodges, A., Powell, J., Wahlund, L.-O., Kloszewska, I., et al. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.123 · Cited by 157
Self-citationPredicting conversion from MCI to AD by integrating rs-fMRI and structural MRI
Hojjati, S. H., Ebrahimzadeh, A., Khazaee, A., & Abbas Babajani-feremi, A. (2018) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2018.09.004 · Cited by 157
Neuroimaging and Other Biomarkers for Alzheimer's Disease: The Changing Landscape of Early Detection
Risacher, S. L., & Saykin, A. J. (2013) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-050212-185535 · Cited by 163
Self-citationElectromagnetic signatures of the preclinical and prodromal stages of Alzheimer’s disease
Nakamura, A., Cuesta, P., Fernández, A., Arahata, Y., Iwata, K., Kuratsubo, I., Bundo, M., Hattori, H., Sakurai, T., Fukuda, K., et al. (2018) · Brain · doi:10.1093/brain/awy044 · Cited by 151
Adjusting the effect of nonstationarity in cluster-based and TFCE inference
Salimi‐Khorshidi, G., Smith, S. M., & Nichols, T. E. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.09.088 · Cited by 150
Conroy, S. K., McDonald, B. C., Smith, D. J., Moser, L. R., West, J. D., Kamendulis, L. M., Klaunig, J. E., Champion, V. L., Unverzagt, F. W., & Saykin, A. J. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2385-x · Cited by 147
Self-citationThe role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI)
Risacher, S. L. (2013) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2013.00011 · Cited by 151
Self-citationNeuroimaging Biomarkers of Neurodegenerative Diseases and Dementia
Risacher, S. L., & Saykin, A. J. (2013) · Seminars in Neurology · doi:10.1055/s-0033-1359312 · Cited by 155
Self-citationEFNS task force: the use of neuroimaging in the diagnosis of dementia
Filippi, M., Agosta, F., Barkhof, F., Dubois, B., Fox, N. C., Frisoni, G. B., Jack, C. R., Johannsen, P., Miller, B. L., Nestor, P. J., et al. (2012) · European Journal of Neurology · doi:10.1111/j.1468-1331.2012.03859.x · Cited by 141
Maruszak, A., & Thuret, S. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00095 · Cited by 147
Sun, Y. R., Herrmann, N., Scott, C. J. M., Black, S. E., Khan, M. M., & Lanctôt, K. L. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.08.078 · Cited by 142
Analysis of the MIRIAD Data Shows Sex Differences in Hippocampal Atrophy Progression
Ardekani, B. A., Convit, A., & Bachman, A. H. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-150780 · Cited by 141
Biomarkers for Alzheimer's disease therapeutic trials
Hampel, H. J., Wilcock, G. K., Andrieu, S., Aisen, P. S. S., Blennow, K., Broich, K., Carrillo, M. C., Fox, N. C., Frisoni, G. B., Isaac, M., et al. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.11.005 · Cited by 140
Cerebral cortical thickness in patients with type 2 diabetes
Brundel, M., van den Heuvel, M. P., de Bresser, J., Kappelle, L. J., & Biessels, G. J. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.08.048 · Cited by 133
Hippocampal atrophy based Alzheimer’s disease diagnosis via machine learning methods
Uysal, G., & Öztürk, M. (2020) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2020.108669 · Cited by 131
Yi, H., Möller, C., Dieleman, N., Bouwman, F. H., Barkhof, F., Scheltens, P., van der Flier, W. M., & Vrenken, H. (2015) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-309105 · Cited by 139
Trzepacz, P. T., Yu, P., Sun, J., Schuh, K. J., Case, M. G., Witte, M. M., Hochstetler, H. M., & Hake, A. M. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.06.018 · Cited by 131
Genetic architecture of Alzheimer's disease
Neuner, S. M., TCW, J., & Goate, A. M. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104976 · Cited by 126
“they reliably predict cognitive decline [222], are heritable [223, 224], and are readily quantifiable by magnetic resonance imaging (MRI).”
Prediction of Conversion to Alzheimer’s Disease with Longitudinal Measures and Time-To-Event Data
Li, K., Chan, W., Doody, R. S., Quinn, J., Luo, S., & Initiative, T. A. D. N. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-161201 · Cited by 126
Esposito, R., Cieri, F., Chiacchiaretta, P., Cera, N., Lauriola, M., Giannantonio, M. D., Tartaro, A., & Ferretti, A. (2017) · Brain Imaging and Behavior · doi:10.1007/s11682-017-9686-y · Cited by 133
Tartaglia, M. C., Rosen, H. J., & Miller, B. L. (2011) · Neurotherapeutics · doi:10.1007/s13311-010-0012-2 · Cited by 124
Yao, J., Rettberg, J. R., Klosinski, L. P., Cadenas, E., & Brinton, R. D. (2011) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2011.10.005 · Cited by 125
Karakis, I., Pase, M. P., Beiser, A., Booth, S. L., Jacques, P. F., Rogers, G. T., DeCarli, C. S., Vasan, R. S., Wang, T. J., Himali, J. J., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150991 · Cited by 124
Feng, F., Wang, P., Zhao, K., Zhou, B., Yao, H., Meng, Q., Wang, L., Zhang, Z., Ding, Y., Wang, L., et al. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00290 · Cited by 122
Düzel, E., Schütze, H., Yonelinas, A. P., & Heinze, H. (2010) · Hippocampus · doi:10.1002/hipo.20834 · Cited by 124
Schinka, J. A., Loewenstein, D., Raj, A., Schoenberg, M. R., Banko, J. L., Potter, H., & Duara, R. (2010) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181e56d5a · Cited by 117
Plasma long-chain omega-3 fatty acids and atrophy of the medial temporal lobe
Samieri, C., Maillard, P., Crivello, F., Proust‐Lima, C., Peuchant, E., Helmer, C., Amieva, H., Michèle Allard, A., Dartigues, J., Cunnane, S. C., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e318264e394 · Cited by 123
Liu, Y., Paajanen, T. I., Zhang, Y., Westman, E., Wahlund, L., Simmons, A., Tunnard, C., Sobów, T., Mecocci, P., Tsolaki, M., et al. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.01.022 · Cited by 115
Alzheimer's disease including focal presentations
Villain, N., & Dubois, B. (2019) · Seminars in Neurology · doi:10.1055/s-0039-1681041 · Cited by 113
Sex differences in grey matter atrophy patterns among AD and aMCI patients: Results from ADNI
Skup, M., Hongtu Zhu, B., Wang, Y., Giovanello, K. S., Lin, J.-A., Shen, D. G., Shi, F., Gao, W., Lin, W., Yong Fan, A., et al. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.02.060 · Cited by 124
Identification of the Early Stage of Alzheimer's Disease Using Structural MRI and Resting-State fMRI
Hojjati, S. H., Ebrahimzadeh, A., & Abbas Babajani-feremi, A. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00904 · Cited by 105
Potential Predictors of Hippocampal Atrophy in Alzheimerʼs Disease
Dhikav, V., & Anand, K. S. (2010) · Drugs & Aging · doi:10.2165/11586390-000000000-00000 · Cited by 110
Meditation for Adults with Mild Cognitive Impairment: A Pilot Randomized Trial
Wells, R. E., Kerr, C. E., Wolkin, J., Dossett, M., Davis, R. B., Walsh, J., Wall, R. B., Kong, J., Kaptchuk, T., Press, D., et al. (2013) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12179 · Cited by 106
Grey matter atrophy in prodromal stage of dementia with Lewy bodies and Alzheimer’s disease
Blanc, F., Colloby, S. J., Cretin, B., de Sousa, P. L., Demuynck, C., O'Brien, J. T., Martin‐Hunyadi, C., McKeith, I. G., Philippi, N., & Taylor, J. (2016) · Alzheimer s Research & Therapy · doi:10.1186/s13195-016-0198-6 · Cited by 102
How Can Insulin Resistance Cause Alzheimer’s Disease?
Yoon, J. H., Hwang, J., Son, S. U., Choi, J., You, S.-W., Park, H., Cha, S.-Y., & Maeng, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043506 · Cited by 106
Belleville, S., Fouquet, C., Duchesne, S., Collins, D. L., & Hudon, C. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-141470 · Cited by 114
Multimodal manifold-regularized transfer learning for MCI conversion prediction
Initiative, A. D. N., Cheng, B., Liu, M., Suk, H., Shen, D. G., & Zhang, D. (2015) · Brain Imaging and Behavior · doi:10.1007/s11682-015-9356-x · Cited by 101
Vitali, P., Migliaccio, R., Agosta, F., Rosen, H., & Geschwind, M. D. (2008) · Seminars in Neurology · doi:10.1055/s-0028-1083695 · Cited by 105
Progressive regional atrophy in normal adults with a maternal history of Alzheimer disease
Honea, R. A., Swerdlow, R. H., Vidoni, E. D., & Burns, J. M. (2011) · Neurology · doi:10.1212/wnl.0b013e31820e7b74 · Cited by 99
Clerx, L., van Rossum, I. A., Burns, L., Knol, D. L., Scheltens, P., Verhey, F., Aalten, P., Lapuerta, P., van de Pol, L., van Schijndel, R., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.02.002 · Cited by 98
Estrogen Regulation of Mitochondrial Bioenergetics
Yao, J., & Brinton, R. D. (2012) · Advances in pharmacology · doi:10.1016/b978-0-12-394816-8.00010-6 · Cited by 103
FLCRM: Functional Linear Cox Regression Model
Kong, D., Ibrahim, J. G., Lee, E., & Hongtu Zhu, B. (2017) · Biometrics · doi:10.1111/biom.12748 · Cited by 93
Structural networks in Alzheimer's disease
Reid, A., & Evans, A. C. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.11.010 · Cited by 94
Bos, D. J., van Montfort, S. J. T., Oranje, B., Durston, S., & Smeets, P. A. M. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.12.031 · Cited by 99
A Disease State Fingerprint for Evaluation of Alzheimer's Disease
Mattila, J., Initiative, A. F. T. A. D. N., Koikkalainen, J. R., Virkki, A., Simonsen, A. H., van Gils, M., Waldemar, G., Soininen, H. S., & Lötjönen, J. M. P. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110365 · Cited by 89
Multi-Domain Transfer Learning for Early Diagnosis of Alzheimer’s Disease
Initiative., T. A. D. N., Cheng, B., Liu, M., Shen, D. G., Li, Z., & Zhang, D. (2016) · Neuroinformatics · doi:10.1007/s12021-016-9318-5 · Cited by 87
McDonald, B. C., & Saykin, A. J. (2013) · Brain Imaging and Behavior · doi:10.1007/s11682-013-9256-x · Cited by 90
Self-citationFamily History of Alzheimer's Disease and Hippocampal Structure in Healthy People
Donix, M., Burggren, A. C., Suthana, N., Siddarth, P., Ekstrom, A. D., Krupa, A. K., Jones, M., Martin‐Harris, L., Ercoli, L. M., Miller, K. J., et al. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.09111575 · Cited by 88
Nicolini, P., Ciulla, M. M., Malfatto, G., Abbate, C., Mari, D., Rossi, P. D., Pettenuzzo, E., Magrini, F., Consonni, D., & Lombardi, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096656 · Cited by 88
Nho, K. T., Corneveaux, J. J., Kim, S., Lin, H., Risacher, S. L., Shen, L., Swaminathan, S., Ramanan, V. K., Liu, Y., Foroud, T., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.24 · Cited by 81
Self-citationEtiology and Pathogenesis of Late-Onset Alzheimer’s Disease
Balin, B. J., & Hudson, A. P. (2014) · Current Allergy and Asthma Reports · doi:10.1007/s11882-013-0417-1 · Cited by 86
Metadata
- Authors
- Risacher, S., Saykin, A., Wes, J., Shen, L., Firpi, H., & McDonald, B.
- Affiliations
- Indiana University School of Medicine (US)
- Indiana University Bloomington (US)
- Corresponding author
- Saykin, Andrew
- Venue
- Current Alzheimer Research
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2009-08-01
- Volume
- 6
- Issue
- 4
- Pages
- 347-361
- ISSN
- 1567-2050 (ISSN-L)
- PMC
- PMC2764863
- OpenAlex
- W2128422359
- Cited by
- 538
- References
- 90
- Citations by year
- 2026: 18 · 2025: 11 · 2024: 21 · 2023: 23 · 2022: 20 · 2021: 29 · 2020: 39 · 2019: 36 · 2018: 44 · 2017: 38 · 2016: 41 · 2015: 29 · 2014: 31 · 2013: 46 · 2012: 33
- FWCI
- 22.68
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Current Alzheimer Research (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- IUScholarWorks (Indiana University) (submittedVersion, cc-by)
- Funders
- Brigham Young University
- National Institutes of Health (5u01ag024904-10)
- School of Medicine, Indiana University
- National Institute on Aging (U01-AG-024904, P30AG010133, R01 AG19771, R01AG019771, U19AG010483, P30 AG-10133)
- National Institute of Biomedical Imaging and Bioengineering (R03EB008674)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Keywords
- Alzheimer's disease, amnestic mild cognitive impairment, neuroimaging biomarkers, hippocampal volume, gray matter density, amygdala, entorhinal cortex, cortical thickness, medial temporal lobe atrophy, structural MRI, voxel-based morphometry, MPRAGE, disease progression prediction
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Analysis of Variance, Atrophy, Brain Mapping, Cerebral Cortex, Cognition Disorders, Female, Hippocampus, Humans, Image Interpretation, Computer-Assisted, Image Processing, Computer-Assisted, Magnetic Resonance Imaging, Male, Middle Aged, Neuropsychological Tests, Organ Size, Predictive Value of Tests, Multivariate Analysis, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review